FDA
-
-
-
-
-
-
-
HeartBeam closes $10 million stock offering led by commercial customer
-
-
-
-
-
-
-
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
-
-
-
-
-
-
-
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
-
-
-
-
-
-
-
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
-
-
-
-
-
-
-
HeartBeam AI shows comparable accuracy to standard ECGs for arrhythmias
-
-
-
-
-
-
-
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025
-
-
-
-
-
-
-
HeartBeam, Inc (BEAT) Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
-
322,248 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

